English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

There is evidence of a two-way interaction between gastric acid secretion and  H. pylori -associated gastritis. Gastric acid secretion influences the density of  H. pylori  colonisation, its distribution within the stomach and the severity of the mucosal inflammatory response to the infection. In addtion,  H. pylori  gastritis alters gastric acid secretion. In subjects with a predominant antral gastritis, it increases acid secretion predisposing to duodenal ulcer, whereas in others with predominant body gastritis, acid secretion is impaired an the subjects have an increased risk of gastric cancer. The two-way interaction between acid secretion and  H. pylori  is observed when  H. pylori -positive subjects are treated with proton pump inhibitor agents. The inhibition of acid secretion induces a body gastritis and this inflammation of the body mucosa inhibits acid secretion thus augmenting the anti-secretory effect of the drug. In this article, we discuss the interaction between gastric acid secretion and  H. pylori  gastritis and its importance in determining disease outcome.

Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy